retatrutide first week UK 2026: Phase 3 Results Retatrutide—A Game Changer in Obesity
Description
GLP-1 therapy works best for patients motivated to adopt lifestyle changes alongside medication use
The target audience
M., & Acosta, A
GLP-1 prescriptions for those aged 18 to 39 increased 588%, from 0.19% in 2019 to 1.33% in 2024
For comparison, fewer than half of those on placebo reported similar symptoms
